ILMN Sep 2024 115.000 call
| Previous close | 8.60 |
| Open | 8.60 |
| Bid | 12.90 |
| Ask | 13.50 |
| Strike | 115.00 |
| Expiry date | 2024-09-20 |
| Day's range | 8.60 - 15.40 |
| Contract range | N/A |
| Volume | |
| Open interest | 259 |
PR NewswireIllumina launches latest chemistry across most popular mid-throughput sequencers, enabling higher quality and greater speed for customers at lower cost
Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced that it has completed integration of its latest chemistry, XLEAP-SBS™, into all reagents for its NextSeq™ 1000 and NextSeq 2000 next-generation sequencing (NGS) instruments.
- Investing.com
Futures lower, JOLTS ahead, GameStop surges - what's moving markets
Investing.com -- U.S. stock futures slip following a volatile session on Monday. Traders are looking ahead to the release of key job openings data, which could provide a fresh glimpse into the state of the U.S. labor market. GameStop (NYSE:GME) shares move higher in after-hours trading, suggesting an extension in a Monday rally in the videogame retailer that was fueled by the return of stock influencer Keith Gill to social media website Reddit.
ReutersIllumina's board approves to spin off Grail in June
Shareholders will receive one common share of Grail for every six shares of Illumina, which will retain a 14.5% stake in the unit after the spinoff on June 24. Shares of Illumina were up 4% in extended trading. The gene sequencing machine maker founded Grail and spun it off in 2016, but re-acquired it in 2021 for $7.1 billion to enter the cancer early-detection market.
